Diabetic Retinopathy Market Size, Share & Trends Analysis Report By Type (Proliferative Diabetic Retinopathy, Non-proliferative Diabetic Retinopathy), By Treatment Type (Anti-VEGF Drug, Steroid Implants, Laser Surgeries, Vitrectomy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR151DR | Pages: 110

Market Segmentation

  1. Diabetic Retinopathy Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Proliferative Diabetic Retinopathy
    2. Non-proliferative Diabetic Retinopathy
  2. Diabetic Retinopathy Market, By Treatment Type 2022-2034 (USD MILLION/ Units)
    1. Anti-VEGF Drug
    2. Steroid Implants
    3. Laser Surgeries
    4. Vitrectomy
  3. Regional Diabetic Retinopathy Market
    1. North America
      1. North America Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. North America Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. U.S. Diabetic Retinopathy Market
        1. U.S. Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. U.S. Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      4. Canada Diabetic Retinopathy Market
        1. Canada Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Canada Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
    2. Europe
      1. Europe Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. Europe Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. U.K. Diabetic Retinopathy Market
        1. U.K. Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. U.K. Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      4. Germany Diabetic Retinopathy Market
        1. Germany Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Germany Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      5. France Diabetic Retinopathy Market
        1. France Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. France Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      6. Spain Diabetic Retinopathy Market
        1. Spain Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Spain Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      7. Italy Diabetic Retinopathy Market
        1. Italy Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Italy Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      8. Russia Diabetic Retinopathy Market
        1. Russia Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Russia Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      9. Nordic Diabetic Retinopathy Market
        1. Nordic Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Nordic Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      10. Benelux Diabetic Retinopathy Market
        1. Benelux Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Benelux Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      11. Rest of Europe Diabetic Retinopathy Market
        1. Rest of Europe Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Rest of Europe Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
    3. APAC
      1. APAC Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. APAC Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. China Diabetic Retinopathy Market
        1. China Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. China Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      4. Korea Diabetic Retinopathy Market
        1. Korea Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Korea Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      5. Japan Diabetic Retinopathy Market
        1. Japan Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Japan Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      6. India Diabetic Retinopathy Market
        1. India Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. India Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      7. Australia Diabetic Retinopathy Market
        1. Australia Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Australia Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      8. Singapore Diabetic Retinopathy Market
        1. Singapore Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Singapore Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      9. Taiwan Diabetic Retinopathy Market
        1. Taiwan Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Taiwan Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      10. South East Asia Diabetic Retinopathy Market
        1. South East Asia Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. South East Asia Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      11. Rest of Asia-Pacific Diabetic Retinopathy Market
        1. Rest of Asia-Pacific Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Rest of Asia-Pacific Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
    4. Middle East and Africa
      1. Middle East and Africa Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. Middle East and Africa Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. UAE Diabetic Retinopathy Market
        1. UAE Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. UAE Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      4. Turkey Diabetic Retinopathy Market
        1. Turkey Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Turkey Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      5. Saudi Arabia Diabetic Retinopathy Market
        1. Saudi Arabia Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Saudi Arabia Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      6. South Africa Diabetic Retinopathy Market
        1. South Africa Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. South Africa Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      7. Egypt Diabetic Retinopathy Market
        1. Egypt Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Egypt Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      8. Nigeria Diabetic Retinopathy Market
        1. Nigeria Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Nigeria Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      9. Rest of MEA Diabetic Retinopathy Market
        1. Rest of MEA Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Rest of MEA Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
    5. LATAM
      1. LATAM Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
        1. Proliferative Diabetic Retinopathy
        2. Non-proliferative Diabetic Retinopathy
      2. LATAM Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Anti-VEGF Drug
        2. Steroid Implants
        3. Laser Surgeries
        4. Vitrectomy
      3. Brazil Diabetic Retinopathy Market
        1. Brazil Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Brazil Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      4. Mexico Diabetic Retinopathy Market
        1. Mexico Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Mexico Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      5. Argentina Diabetic Retinopathy Market
        1. Argentina Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Argentina Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      6. Chile Diabetic Retinopathy Market
        1. Chile Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Chile Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      7. Colombia Diabetic Retinopathy Market
        1. Colombia Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Colombia Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
      8. Rest of LATAM Diabetic Retinopathy Market
        1. Rest of LATAM Diabetic Retinopathy Market By Type 2022-2034 (USD MILLION/ Units)
          1. Proliferative Diabetic Retinopathy
          2. Non-proliferative Diabetic Retinopathy
        2. Rest of LATAM Diabetic Retinopathy Market By Treatment Type 2022-2034 (USD MILLION/ Units)
          1. Anti-VEGF Drug
          2. Steroid Implants
          3. Laser Surgeries
          4. Vitrectomy
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: